Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Charles E. Argoff & Ernest A. Kopecky. (2014) Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options. Current Medical Research and Opinion 30:12, pages 2543-2559.
Read now
Read now
Noam Y. Kirson, Alan G. White, Howard G. Birnbaum, Matt Schiller, Tracy Waldman, Kirsten Peterson, Rami H. Ben-Joseph, Todd Berner & Kent H. Summers. (2012) Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl. Journal of Medical Economics 15:1, pages 87-95.
Read now
Read now
Articles from other publishers (12)
Jessica Z. Song, Dorothy Luong, Estée C. H. Feldman, Susan Tran, Laure Perrier, Kathleen Eubanks, Mark Bayley, Monika Kastner, Maxwell Slepian & Sarah E. P. Munce. (2023) Psychological interventions for individuals with Ehlers-Danlos syndrome and hypermobility spectrum disorder: a scoping review. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Víctor Mayoral Rojals, Ángeles Canós Verdecho & Begoña Soler López. (2022) Assessment of the Management of Patients with Chronic Pain Referred to a Specialized Pain Unit: A Cross-Sectional Multicenter Study (the DUO Project). Journal of Clinical Medicine 11:13, pages 3586.
Crossref
Crossref
Marit Dagny Kristine Jenssen, Per Atle Bakkevoll, Phuong Dinh Ngo, Andrius Budrionis, Asbjørn Johansen Fagerlund, Maryam Tayefi, Johan Gustav Bellika & Fred Godtliebsen. (2021) Machine Learning in Chronic Pain Research: A Scoping Review. Applied Sciences 11:7, pages 3205.
Crossref
Crossref
Arnold J. Weil, Elizabeth T. Masters, Alexandra I. Barsdorf, Almasa Bass, Glenn Pixton, Jacquelyn G. Wilson & Gernot Wolfram. (2017) Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref
Ernest A. Kopecky, Ben Vaughn, Scott Lagasse & Melinda O’Connor. (2017) Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial. Drugs & Aging 34:8, pages 603-613.
Crossref
Crossref
Kelly A. Pollak, Linda S. Stephens, Karen L. Posner, James P. Rathmell, Dermot R. Fitzgibbon, Richard P. Dutton, Edward Michna & Karen B. Domino. (2015) Trends in Pain Medicine Liability. Anesthesiology 123:5, pages 1133-1141.
Crossref
Crossref
Katja Marja Hakkarainen, Karolina Andersson Sundell, Max Petzold & Staffan Hägg. (2013) Prevalence and Perceived Preventability of Self-Reported Adverse Drug Events – A Population-Based Survey of 7099 Adults. PLoS ONE 8:9, pages e73166.
Crossref
Crossref
Sebastiano Mercadante, David Craig & Antonello Giarratano. (2012) US Food and Drug Administrationʼs Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids. Drugs 72:18, pages 2327-2332.
Crossref
Crossref
Ersilia Lucenteforte, Francesca Collini, Monica Simonetti, Andrea Messeri, Simona Caprilli, Laura Rasero, Francesco Lapi, Galileo Guidi, Marianna Scollo Abeti, Alessandro Mugelli & Stefania Rodella. (2012) Assessing pain in hospital in-patients: a cross-sectional study in Tuscany, Italy. Internal and Emergency Medicine 7:5, pages 477-482.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Supportive & Palliative Care 5:2, pages 174-183.
Crossref
Crossref
M.-L. Sigal, M. Rafaa & J.-L. Caravias. (2011) Prise en charge de la douleur en dermatologie : les opioïdes forts. Annales de Dermatologie et de Vénéréologie 138:6-7, pages 524-529.
Crossref
Crossref
Eleanor T. Lewis & Jodie A. Trafton. (2011) Opioid Use in Primary Care: Asking the Right Questions. Current Pain and Headache Reports 15:2, pages 137-143.
Crossref
Crossref